The 20 Best Retinoblastoma Doctors Near Me in New York, NY

David Abramson is an Oncologist practicing medicine in New York, New York. Dr. Abramson is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Hereditary Retinoblastoma, Melanoma of the Eye, Vitrectomy, and Leg or Foot Amputation. Dr. Abramson is currently accepting new patients.

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network. Dr. Marr is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy. Dr. Marr is board certified in Ophthalmology. Dr. Marr is currently accepting new patients.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, Cone-Rod Dystrophy, and Vitrectomy. Dr. Brodie is currently accepting new patients.

Ira Dunkel is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Dunkel is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Diffuse Midline Glioma H3 K27M-Mutant, Glioma, and Brain Stem Cancer. Dr. Dunkel is currently accepting new patients.

Y Gobin is a Radiologist practicing medicine in New York, New York. Dr. Gobin is rated as an Elite provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Brain Aneurysm, Hereditary Retinoblastoma, Arteriovenous Malformation, and Thrombectomy.

Jennifer O'reilly is a primary care provider, practicing in Internal Medicine in Norwich, New York. Dr. O'reilly is rated as an Experienced provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Ringworm, Maturity Onset Diabetes of the Young, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Jasmine Francis is an Oncologist practicing medicine in New York, New York. Dr. Francis is rated as a Distinguished provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Non-Hodgkin Lymphoma, and Retinoblastoma. Dr. Francis is currently accepting new patients.

Dr. Paul T. Finger has collected or discovered the latest and most advanced medical technologies for the diagnosis and treatment of ocular tumors and eye cancer.With great respect for collaboration, he works closely with you, your referring doctor and his associated specialists to provide the most excellent care possible.The New York Eye Cancer Center was designed to be a responsive and caring environment, we strive to be your and your doctor's first choice for eye cancer care.Dr. Finger is the Director of Ocular Tumor Services at the Manhattan Eye, Ear and Throat Hospital and teaches residents from the New York University School of Medicine.A world-recognized expert in radiation and surgical techniques to conserve the eye and vision; Dr. Finger has pioneered the use of palladium-103 plaque radiation for choroidal melanoma, 3D and high-frequency ultrasound to image intraocular tumors, and created this world-renowned web site. Dr. Finger publishes in the major clinical journals and lectures frequently at local, national and international meetings. He graduated from Tulane Medical School, the Manhattan Eye, Ear and Throat Hospital, and then completed specialty training in treatment of ocular tumors and orbital diseases.Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology and sees patients from all over the world.Dr Finger was a principal investigator for The Collaborative Ocular Melanoma Study. He Chaired the Ophthalmic Oncology Task Force that wrote the 2014 consensus guidelines for plaque radiationt therapy of choroidal melanoma and retinoblastoma for The American Brachytherapy Society. Dr. Finger was the clinical director for the Plaque Radiation Therapy (Task Group 129) of the American Association for Physicists in Medicine (AAPM). Dr. Finger is Chair of the Ophthalmic Oncology Task Group of The American Joint Committee on Cancer (AJCC) - International Union Against Cancer (UICC). The AJCC-UICC has created a universal language (TNM-classification) commonly used around the world to describe eye cancer.Dr. Finger has a particular interest in melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma, squamous carcinoma, metastatic cancer to the eye and orbital tumors.Dr. Finger has assembled a team to care for patients with eye tumors. By picking the best doctors from several institutions, his team includes the top radiation, medical and pediatric oncologists from several institutions in New York City.Dr. Finger has spent his career inventing and improving new methods of diagnosis and treatment for eye cancer:. Dr. Finger is rated as an Advanced provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Iridectomy, and Vitrectomy.

Ekaterina Semenova is an Ophthalmologist practicing medicine in New York, New York. Dr. Semenova is rated as a Distinguished provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Melanoma of the Eye, Retinoblastoma, Choroid Plexus Carcinoma, Metastatic Uveal Melanoma, and Corneal Transplant. Dr. Semenova is currently accepting new patients.

Tarun Sharma is an Ophthalmologist practicing medicine in New York, New York. He has been practicing medicine for over 44 years. Dr. Sharma is rated as an Advanced provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, X-Linked Juvenile Retinoschisis, Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy. Dr. Sharma is currently accepting new patients.

Carolyn Levy is a Pediatric Hematologist Oncology provider practicing medicine in New Hyde Park, New York. Dr. Levy is rated as an Experienced provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Langerhans Cell Histiocytosis, Acute Lymphoblastic Leukemia (ALL), Histiocytosis, Reticulohistiocytoma, and Bone Marrow Aspiration. Dr. Levy is board certified in American Board Of Pediatrics and American Board Of Pediatrics/Hematology-Oncology.

Jamie Rosenberg, MD, is a pediatric ophthalmologist and Professor, Ophthalmology and Pediatrics at Montefiore Einstein. She is also Director, Ophthalmology Residency Program and Co-director, Pediatric Ophthalmology and Strabismus Division. Her clinical focus is in the care of children and teenagers with eye diseases, as well as management of ocular misalignment in children and adults. Dr. Rosenberg is rated as an Experienced provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Strabismus, Brown Syndrome, Ptosis, and Tieche-Jadassohn Nevus.

Bahar Laderian, MD, is Director of the Neuroendocrine Tumors Program at Montefiore Einstein Comprehensive Cancer Center and Assistant Professor of Medicine and Oncology at Albert Einstein College of Medicine. Dr. Laderian’s clinical focus is on the treatment of neuroendocrine tumors (carcinoid), adrenocortical carcinoma and carcinomas, pheochromocytomas, paragangliomas, and gastrointestinal cancers including anal cancers, colorectal cancers, cancer of the appendix, intestinal cancers, anal cancers, pancreatic cancers, hepatocellular carcinomas, cholangiocarcinomas and gastroesophageal cancers. Dr. Laderian is rated as an Experienced provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Glomus Tympanum Tumor, Glomus Jugulare Tumor, Lynch Syndrome, Gastroesophageal Junction Cancer, and Gamma Knife Radiosurgery.

Manuela Orjuela-Grimm is a molecular epidemiologist and pediatric oncologist whose research focuses on vulnerability (including social) to environmental exposures, gene-nutrient/ environment interactions during windows of susceptibility such as pregnancy, early childhood, adolescence and the development of later genetic and epigenetic changes contributing to poorer health outcomes in childhood and adolescence. She leads EpiRbMx, a long-standing case control/ case series study examining exposure to methyl donors, folate pathway metabolism and risk for retinoblastoma in collaboration with a multidisciplinary team of investigators including the Hospital Infantil de Mexico, the Hospital de Pediatria at the Instituto Mexicano de Seguro Social (IMSS), the Instituto Nacional de Salud Publica (INSP), and the University of Toronto. In collaboration with INSP researchers, Dr. Orjuela is involved in multiple studies examining the intersection between food security, folate-related dietary intake, dietary diversity and environmental exposures in central Mexico, and in immigrants in New York.Interests: social contributors to dietary exposures, gene-nutrient interactions; one carbon donor metabolism; methylation; nutrient and environmental exposures during early life and later genetic and epigenetic effects; dietary assessment in Mexico, in populations on the move in Latin America; effects of acculturation and early life migration on nutrient/ environmental exposures in US Latinos. Dr. Orjuela is rated as an Advanced provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Retinoblastoma, Hereditary Retinoblastoma, Acute Lymphoblastic Leukemia (ALL), and Hepatoblastoma. Dr. Orjuela is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Orjuela is currently accepting new patients.

Helena Yu is an Oncologist practicing medicine in New York, New York. Dr. Yu is rated as an Advanced provider by MediFind in the treatment of Retinoblastoma. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Yu is currently accepting new patients.

Kevin Oeffinger is a primary care provider, practicing in Family Medicine in New York, New York. Dr. Oeffinger is rated as an Advanced provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Cardiomyopathy Due to Anthracyclines, Wilms Tumor, Hodgkin Lymphoma, Splenectomy, and Colonoscopy.

Charles Rudin is an Oncologist practicing medicine in New York, New York. Dr. Rudin is rated as an Advanced provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Tissue Biopsy. Dr. Rudin is currently accepting new patients.

Matthias Karajannis is an Oncologist practicing medicine in New York, New York. Dr. Karajannis is rated as an Advanced provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Neurofibromatosis, Glioma, Medulloblastoma, and Brain Stem Cancer. Dr. Karajannis is currently accepting new patients.

Mark Dickson is an Oncologist practicing medicine in New York, New York. Dr. Dickson is rated as an Experienced provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Undifferentiated Pleomorphic Sarcoma, Synovial Sarcoma, and Endoscopy. Dr. Dickson is currently accepting new patients.

David Solit is an Oncologist practicing medicine in New York, New York. Dr. Solit is rated as an Experienced provider by MediFind in the treatment of Retinoblastoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, PIK3CA-Related Overgrowth Spectrum, Tissue Biopsy, and Nephrectomy. Dr. Solit is currently accepting new patients.